In 2003, we handled more than 100 M&A transactions. In the past five years, we have completed more than 700 mergers and acquisitions valued in excess of $100 billion. The following are selected highlights from our 2003 transactions:
- Alnylam Pharmaceuticals — merger with Ribopharma — undisclosed
- Applix — sale of CRM business to Platinum Equity — $8.75 million
- Bookham Technology — pending acquisition of New Focus — $330.5 million
- Braintree Laboratories — sale of worldwide rights to PhosLo® (calcium acetate) to Nabi Biopharmaceuticals — $101 million
- Casella Waste Systems — acquisition of Hardwick Sanitary Landfill — undisclosed
- CCBN — acquisition of corporate earnings call transcript and webcast distribution business from Fair Disclosure Financial Network — undisclosed
- CMGI — sale of AltaVista to Overture Services — $140 million
- Diacrin — merger with GenVec — $40.4 million
- DoubleClick — acquisition of CSC Advanced Database Solutions — undisclosed
- Fabric Networks — merger with Lane15 Software — undisclosed
- Idenix Pharmaceuticals — acquisition of 51% interest by Novartis — $255 million
- IDX Systems — sale of EDiX to Total eMed — $64 million
- LTX Corporation — acquisition of StepTech — undisclosed
- Manufacturers' Services Limited — pending acquisition by Celestica — $293 million
- MapInfo — acquisition of Thompson Associates — $13 million plus earnout
- Penwest Pharmaceuticals — sale of excipient business to Josef Rettenmaier Holding — $41.75 million
- Proton Energy Systems — pending acquisition of Northern Power Systems — $27.5 million plus warrants
- SpeechWorks International — acquisition by ScanSoft — $132 million
- uDate.com — acquisition by USA Interactive — $150 million
- VitalWorks — acquisition of Amicas — $30 million plus earnout
- Winphoria Networks — acquisition by Motorola — $175 million